{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:54:14Z","timestamp":1769043254990,"version":"3.49.0"},"reference-count":27,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,9,29]]},"DOI":"10.1536\/ihj.21-106","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T22:09:06Z","timestamp":1631830146000},"page":"980-987","source":"Crossref","is-referenced-by-count":4,"title":["Serum Angiopoietin-Like Protein 2 and NT-Pro BNP Levels and Their Associated Factors in Patients with Chronic Heart Failure Participating in a Phase III Cardiac Rehabilitation Program"],"prefix":"10.1536","volume":"62","author":[{"given":"Chiharu","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Health Science, Kansai Medical University"},{"name":"Division of Cardiology, Department of Medicine II, Kansai Medical University"},{"name":"Health Science Center, Kansai Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kurose","sequence":"additional","affiliation":[{"name":"Department of Health Science, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Morinaga","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Takao","sequence":"additional","affiliation":[{"name":"Department of Health Science, Kansai Medical University"},{"name":"Health Science Center, Kansai Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Health Science, Kansai Medical University"},{"name":"Health Science Center, Kansai Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Department of Health Science, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Shiojima","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine II, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Oike","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Health Science, Kansai Medical University"},{"name":"Division of Cardiology, Department of Medicine II, Kansai Medical University"},{"name":"Health Science Center, Kansai Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Okura Y, Ramadan MM, Ohno Y, <i>et al<\/i>. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 2008; 72: 489-91.","DOI":"10.1253\/circj.72.489"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Virani SS, Alonso A, Benjamin EJ, <i>et al<\/i>. Heart Disease and Stroke Statistics-2020 Update: a report from the American Heart Association. Circulation 2020; 141: e139-596.","DOI":"10.1161\/CIR.0000000000000746"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Conrad N, Judge A, Tran J, <i>et al<\/i>. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 2018; 391: 572-80.","DOI":"10.1016\/S0140-6736(17)32520-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ades PA, Keteyian SJ, Balady GJ, <i>et al<\/i>. Cardiac rehabilitation exercise and self-care for chronic heart failure. JACC Heart Fail 2013; 1: 540-7.","DOI":"10.1016\/j.jchf.2013.09.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Piepoli MF, Davos C, Francis DP, Coats AJS, ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004; 328: 189.","DOI":"10.1136\/bmj.37938.645220.EE"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Onishi T, Shimada K, Sato H, <i>et al<\/i>. Effects of phase III cardiac rehabilitation on mortality and cardiovascular events in elderly patients with stable coronary artery disease. Circ J 2010; 74: 709-14.","DOI":"10.1253\/circj.CJ-09-0638"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Anand IS, Fisher LD, Chiang YT, <i>et al<\/i>. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-83.","DOI":"10.1161\/01.CIR.0000054164.99881.00"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sarullo FM, Gristina T, Brusca I, <i>et al<\/i>. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure. Eur J CardioVasc Prevent Rehab 2006; 13: 812-7.","DOI":"10.1097\/01.hjr.0000238396.42718.61"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Santulli G. Angiopoietin-like proteins: a comprehensive look. Front Endocrinol 2014; 5: 4.","DOI":"10.3389\/fendo.2014.00004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kadomatsu T, Endo M, Miyata K, Oike Y. Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab 2014; 25: 245-54.","DOI":"10.1016\/j.tem.2014.03.012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Horio E, Kadomatsu T, Miyata K, <i>et al<\/i>. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol 2014; 34: 790-800.","DOI":"10.1161\/ATVBAHA.113.303116"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tazume H, Miyata K, Tian Z, <i>et al<\/i>. Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2012; 32: 1400-9.","DOI":"10.1161\/ATVBAHA.112.247866"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tabata M, Kadomatsu T, Fukuhara S, <i>et al<\/i>. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009; 10: 178-88.","DOI":"10.1016\/j.cmet.2009.08.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tian Z, Miyata K, Kadomatsu T, <i>et al<\/i>. ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism. Nat Commun 2016; 7: 13016.","DOI":"10.1038\/ncomms13016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Huang CL, Wu YW, Wu CC, Hwang JJ, Yang WS. Serum angiopoietin-like protein 2 concentrations are independently associated with heart failure. PLOS ONE 2015; 10: e0138678.","DOI":"10.1371\/journal.pone.0138678"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Larouche JF, Yu C, Luo X, <i>et al<\/i>. Acute high-intensity intermittent aerobic exercise reduces plasma angiopoietin-like 2 in patients with coronary artery disease. Can J Cardiol 2015; 31: 1232-9.","DOI":"10.1016\/j.cjca.2015.01.038"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Thorin-Trescases N, Hayami D, Yu C, <i>et al<\/i>. Exercise lowers plasma angiopoietin-like 2 in men with post-acute coronary syndrome. PLOS ONE 2016; 11: e0164598.","DOI":"10.1371\/journal.pone.0164598"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tsutsui H, Isobe M, Ito H, <i>et al<\/i>. on behalf of the Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017\/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure-digest version. Circ J 2019; 83: 2084-184.","DOI":"10.1253\/circj.CJ-19-0342"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol 2019; 23: 1-15.","DOI":"10.1007\/s10157-018-1648-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Oike Y, Tabata M. Angiopoietin-like proteins potential therapeutic targets for metabolic syndrome and cardiovascular disease. Circ J 2009; 73: 2192-7.","DOI":"10.1253\/circj.CJ-09-0710"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cao Y, Li R, Zhang F, Guo Z, Tuo S, Li Y. Correlation between angiopoietin-like proteins in inflammatory mediators in peripheral blood and severity of coronary arterial lesion in patients with acute myocardial infarction. Exp Ther Med 2019; 17: 3495-500.","DOI":"10.3892\/etm.2019.7386"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shimomura M, Oyama J, Takeuchi M, <i>et al<\/i>. Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (statin for acute myocardial infarction Trial). Heart Vessels 2016; 31: 1583-9.","DOI":"10.1007\/s00380-015-0773-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Usui T, Ninomiya T, Nagata M, <i>et al<\/i>. Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study. Circ J 2013; 77: 2311-7.","DOI":"10.1253\/circj.CJ-12-1548"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.","DOI":"10.1056\/NEJM199902113400607"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zhao J, Tian Z, Kadomatsu T, <i>et al<\/i>. Age-dependent increase in angiopoietin-like protein 2 accelerates skeletal muscle loss in mice. J Biol Chem 2018; 293: 1596-609.","DOI":"10.1074\/jbc.M117.814996"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tomono J, Adachi H, Oshima S, Kurabayashi M. Usefulness of anaerobic threshold to peak oxygen uptake ratio to determine the severity and pathophysiological condition of chronic heart failure. J Cardiol 2016; 68: 373-8.","DOI":"10.1016\/j.jjcc.2016.01.002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Adachi H. Cardiopulmonary exercise test. Int Heart J 2017; 58: 654-65.","DOI":"10.1536\/ihj.17-264"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/5\/62_21-106\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:18:47Z","timestamp":1715145527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/5\/62_21-106\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-106","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"article-number":"21-106"}}